Clinical Study

Expression and Prognostic Significance of Wnt7a in Human Endometrial Carcinoma

Table 2

The expressional profile of Wnt7a in endometrial carcinoma and its precursor lesions.

NumberWnt7a expression -value
Negative (%)Positive (%)

Proliferative endometrium12 2 (16.7)10 (83.3)0.004
Secretory endometrium13 1 (7.7)12 (92.3)<0.001
Atrophic endometrium10 1 (10.0) 9 (90.0)0.002
Simple hyperplasia16 3 (18.8)13 (81.2)0.002
Complex hyperplasia17 4 (23.5)13 (76.5)0.004
Endometrial carcinoma7044 (62.9)26 (37.1)ā€‰

Proliferative endometrium versus carcinoma: 0.004; Secretory endometrium versus carcinoma: <0.001; Atrophic endometrium versus carcinoma: 0.002; Simple hyperplasia versus carcinoma: 0.002; Complex hyperplasia versus carcinoma: 0.004 and *Chi-square test.